Trial Profile
Randomized Clinical Trial: 03 (Methylphenidate and Duloxetine)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary) ; Methylphenidate (Primary) ; Cocaine
- Indications Back pain; Chronic fatigue syndrome; Depressive disorders; Diabetic neuropathies; Fibromyalgia; Generalised anxiety disorder; Major depressive disorder; Musculoskeletal pain; Neuropathic pain; Stress incontinence
- Focus Pharmacodynamics
- 22 Jun 2018 Status changed from recruiting to completed.
- 17 Oct 2016 Protocol is amended as per change in official study title, study design from pharmacodynamics to efficacy/safety study, primary endpoint, purpose and patient number.
- 17 Oct 2016 Planned number of patients changed from 16 to 40.